Skip to main content

Publisher: Elsevier

Volume 33, Supplement 3, 1 March 2003

Un germe et sa pathologie - La tuberculose en 2003
pp. 123-123(1)
Author: Perronne, C.

Favourites:
ADD

Facts about tuberculosis control around the world
pp. 124-129(6)
Author: Trebucq, A.

Favourites:
ADD

When to think tuberculosis in adults?
pp. 130-134(5)
Authors: May, T.; Bevilacqua, S.; Dailloux, M.

Favourites:
ADD

When to think tuberculosis in children?
pp. 135-140(6)
Author: Gaudelus, J.

Favourites:
ADD

Problem of latent bacteria
pp. 147-152(6)
Authors: Lagranderie, M.; Balazuc, A.M.; Chavarot, P.; Stern, S.; Marchal, G.

Favourites:
ADD

Microbiological diagnosis of tuberculosis, interest of PCR
pp. 153-158(6)
Authors: Maugein, J.; Bebear, C.

Favourites:
ADD

Epidemiological contribution of molecular typing of tubercle bacilli
pp. 159-166(8)
Authors: Vincent, V.; Gutierrez, M.C.

Favourites:
ADD
Favourites:
ADD

Contribution of animal models for the design of tuberculosis treatment
pp. 173-179(7)
Authors: Lounis, N.; Truffot-Pernot, C.; Veziris, N.; Jarlier, V.

Favourites:
ADD

Treatment challenges of tuberculosis
pp. 180-182(3)
Authors: Housset, B.; Fuhrman, C.

Favourites:
ADD

Multidrug resistance (MDR) of Mycobacterium tuberculosis in France since 1992
pp. 183-187(5)
Authors: Robert, J.; Trystram, D.; Truffot, C.; Grosset, J.

Favourites:
ADD

Should BCG vaccination be discontinued in France?
pp. 188-192(5)
Authors: Levy-Bruhl, D.; Barrault, Y.; Decludt, B.; Schwoebel, V.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more